Mercado de sistemas de composición automatizada: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00010169
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 165
Buy Now

El mercado de sistemas de composición automatizados se valoró en 403,88 millones de dólares en 2019 y se prevé que alcance los 684,17 millones de dólares en 2027; se espera que crezca a una tasa compuesta anual del 7,0 % durante 2020-2027.

Un sistema de composición automatizado es un dispositivo que combina una o más soluciones de medicamentos en un contenedor final. para la administración del paciente. El sistema de composición automatizado ayuda a evitar errores de medicación que ocurren debido a una variedad de factores, como una mala comunicación de gestión entre el médico y el farmacéutico, prácticas críticas de almacenamiento en las farmacias y confusión al usar etiquetas similares. Sin embargo, con los sistemas de preparación automatizados, la precisión y eficiencia de la dosificación de productos compuestos han mejorado y reducido la exposición de los profesionales de la salud a agentes tóxicos. El mercado mundial de sistemas automatizados de preparación de compuestos está impulsado por factores como la creciente adopción de quimioterapia y medicación personalizada, y la creciente necesidad de minimizar los errores de medicación. Sin embargo, el alto costo de los sistemas de composición automatizados impedirá el crecimiento del mercado. Además, es probable que una mayor concientización entre los farmacéuticos ofrezca importantes oportunidades para el crecimiento del mercado global de sistemas automatizados de preparación de compuestos.

Mercados regionales lucrativos de sistemas de preparación de compuestos automatizados


Perspectivas del mercado

Creciente adopción de quimioterapia y medicación personalizada< /p>

El cáncer es una enfermedad devastadora que causa un número significativo de muertes cada año. Debido a la heterogeneidad de la enfermedad, las curas estándar como la quimioterapia o la radiación son una solución eficaz como tratamiento entre la población de pacientes. La quimioterapia es una terapia farmacológica que necesita sustancias químicas potentes para eliminar las células tumorales que se multiplican rápidamente en el cuerpo. La quimioterapia se utiliza con mayor frecuencia para tratar enfermedades malignas, ya que las células cancerosas crecen y aumentan rápidamente en comparación con otras células del cuerpo.

La rápida adopción de terapias novedosas, como Se ha informado que la quimioterapia en oncología proporciona mejores opciones de tratamiento para los cánceres de mama, pulmón y próstata. De igual forma, el área de medicina de precisión y personalizada (PPM) se desarrolla para realizar terapias para un solo paciente o grupos específicos basadas en datos que capturen la experiencia ambiental y de salud física actual y pasada. Recientemente, varios informes muestran que la asimilación del punto de vista de PPM en la investigación y el tratamiento del cáncer dará como resultado mejoras significativas en la lucha contra el cáncer, principalmente debido a su complejidad e imprevisibilidad entre pacientes.

Varios fabricantes ofrecen sistemas de composición automatizados para quimioterapia y medicamentos personalizados. Por ejemplo, Pharmoduct (Comecer) es un dispositivo automatizado que se utiliza para la preparación esterilizada de medicamentos oncológicos personalizados, que incluyen quimioterapia y productos biológicos.

Información sobre productos

< p> Los sistemas de composición automatizados gravimétricos tenían la mayor participación en el mercado mundial de sistemas de composición automatizados. El crecimiento del segmento se atribuye a la creciente adopción de este método para la preparación de agentes intravenosos como los agentes antineoplásicos, junto con la reducción de posibles errores. Además, los actores más conocidos de este mercado están utilizando técnicas gravimétricas en sistemas de automatización de compuestos. Por ejemplo, los sistemas de preparación de compuestos totalmente automatizados, como RIVA, utilizan métodos de medición automatizados precisos y controles gravimétricos para garantizar la exactitud de cada dosis.

Mercado global de sistemas de preparación de compuestos automatizados, Por tipo de producto: 2019 y 2019 2027


Perspectivas del usuario final

Basado en el usuario final, el mercado de sistemas automatizados de composición es segmentados en hospitales, centros de quimioterapia y otros. El segmento de hospitales tuvo la mayor participación en el mercado mundial de sistemas automatizados de composición en 2019. El crecimiento del segmento se atribuye a la exposición a las tendencias globales, el aumento de los errores de medicación y la necesidad de proporcionar los más altos estándares de atención al paciente. Por ejemplo, algunos estudios han observado tasas de error estándar de hasta el 10% en las farmacias hospitalarias. Como resultado, garantizar la seguridad de los medicamentos compuestos y el control de la calidad y el costo de la terapia intravenosa ha sido una prioridad para los hospitales. Es por eso que los sistemas automatizados de preparación de compuestos se consideran un componente esencial de las operaciones farmacéuticas seguras y eficientes. Además, es probable que las iniciativas estratégicas de los principales actores aumenten el crecimiento segmentario en los próximos años. Por ejemplo, Omnicell anunció que Allegheny General Hospital, Pittsburgh, Pa., parte de Allegheny Health Network (AHN), ha colaborado con Omnicell para obtener el servicio de compuestos IV de Central Pharmacy.

A medida que los hospitales reconocen la necesidad de proporcionar los más altos estándares de atención al paciente, es probable que la demanda de sistemas automatizados de preparación aumente a un ritmo constante durante el período de pronóstico.

< p>Información estratégica

Se prevé que las colaboraciones y asociaciones tecnológicas de los actores operativos en el mercado para cerrar la brecha entre la oferta y la demanda desempeñen un papel importante en el crecimiento de la industria de sistemas de composición automatizados durante el período de pronóstico. Además, se prevé que la creciente necesidad de minimizar los errores de medicación acelerará el crecimiento del mercado.

Por tipo de producto

  • Sistemas de composición automatizados gravimétricos
  • Sistemas de composición automatizados volumétricos

Por usuario final

  • Hospitales
  • Centros de quimioterapia
  • Otros

Por geografía

  • América del Norte
    • Estados Unidos
    • Canadá
    • México
  • Europa
    • Francia
    • Alemania
    • Italia
    • Reino Unido
    • Rusia
    • Resto de Europa
  • Asia Pacífico ( APAC)
    • China
    • India
    • Corea del Sur
    • Japón
    • Australia
    • Resto de Asia Pacífico
  • Oriente Medio y Asia. África (MEA)
    • Sudáfrica
    • Arabia Saudita
    • EAU
    • Resto de Medio Oriente y África
  • América del Sur
    • Brasil
    • Argentina
    • Resto de América del Sur

Perfiles de empresas

  • Baxter International Inc.
  • Braun Melsungen AG
  • Comecer
  • ICU MEDICAL INC
  • Grifols, SA
  • OMNICELL INC.
  • EQUASHIELD
  • ARxIUM
  • Tecnología Weibond
  • NewIcon
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the automated compounding systems?

An automated compounding system is a device that combines one or more drug solutions to a final container for patient administration. Automated Compounding System helps avoid medication error that occurs due to a variety of factors such as poor management communication between the physician and pharmacist, critical storage practices in pharmacies, and confusion that was arising out of the use of similar labels.

What are the driving factors for the automated compounding systems market across the globe?

The global automated compounding systems market is being driven by factors such as the growing adoption of chemotherapy and personalized medication, rising need to minimize medication errors. Furthermore, increasing awareness in pharmacists is likely to offer significant opportunities for the growth of the global automated compounding systems.

What are the restraining factors for the automated compounding systems market across the globe?

The high cost of the automated compounding systems is the significant factor that will impede the automated compounding systems market growth. Automated compounding systems have been introduced to the healthcare sector more than a decade ago, but only a few pharmacies use them. The high cost of the devices is one of the significant factors for the hindrance of market growth. Also, disadvantages of automated preparation are the danger of failure/downtime, dependence on the power supply, software (updates), high venture and high maintenance costs, dedicated personnel with extra training, declined worker satisfaction, complication when products are exchanged or added.

The List of Companies - Automated Compounding Systems Market

  1. Baxter International Inc.
  2. Braun Melsungen AG
  3. Comecer
  4. ICU MEDICAL INC
  5. Grifols, S.A.
  6. OMNICELL INC.
  7. EQUASHIELD
  8. ARxIUM
  9. Weibond Technology
  10. NewIcon

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports